Rapid and Successful Treatment of Interstitial Granulomatous Dermatitis With Tofacitinib: A Case Report
Clinical Case Reports · 2026-07 · 14 (7)
DOI: 10.1002/ccr3.73159 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Case Reports, online erschienen am 13.07.2026. Verfasst von Aida Farmani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Skin Diseases and Leishmaniasis Research Center School of Medicine, Isfahan University of Medical Sciences Isfahan Iran. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Interstitial Granulomatous Dermatitis (IGD) is a rare skin condition characterized by granulomatous inflammation. Despite various treatment options, the rarity of this condition makes management challenging. This report highlights the potential of Janus kinase inhibitors, specifically Tofacitinib, as an effective therapy for IGD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Skin Diseases and Leishmaniasis Research Center School of Medicine, Isfahan University of Medical Sciences Isfahan Iran.
ORCID-Profile: Aida Farmani, Mina Saber
Zitieren
APA
Farmani, A., & Saber, M. (2026). Rapid and Successful Treatment of Interstitial Granulomatous Dermatitis With Tofacitinib: A Case Report. Clinical Case Reports, 14(7). https://doi.org/10.1002/ccr3.73159
Vancouver
Farmani A, Saber M. Rapid and Successful Treatment of Interstitial Granulomatous Dermatitis With Tofacitinib: A Case Report. Clinical Case Reports. 2026;14(7). doi:10.1002/ccr3.73159
BibTeX
@article{Farmani2026,
author = {Farmani, Aida and Saber, Mina},
title = {Rapid and Successful Treatment of Interstitial Granulomatous Dermatitis With Tofacitinib: A Case Report},
journal = {Clinical Case Reports},
year = {2026},
volume = {14},
number = {7},
doi = {10.1002/ccr3.73159}
}
EUVIMED